A A Tieleman1, A A den Broeder, A-E van de Logt, B G M van Engelen. 1. Neuromuscular Centre Nijmegen, Department of Neurology (935), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. a.tieleman@neuro.umcn.nl
Abstract
BACKGROUND: Myotonic dystrophy type 2 (DM2) is a dominantly inherited multisystem disorder, characterised by progressive proximal weakness, myotonia, cataracts and cardiac conduction abnormalities. Our clinical impression of an association between DM2 and autoimmune diseases or autoantibody formation has not been published previously. OBJECTIVE: The aim of the present study was to investigate the frequency of autoimmune diseases and serum autoantibodies in patients with DM2 compared with patients with adult onset myotonic dystrophy type 1 (DM1). METHODS: 28 genetically proven Dutch DM2 patients participated in the study and were compared with 51 age and sex matched adult onset DM1 patients. As the primary outcome measure, the presence of an autoantibody or autoreactive T cell associated autoimmune disorder was assessed. As a secondary outcome measure, the presence of autoantibodies in serum (nuclear and non-nuclear antibodies) was assessed in all patients. RESULTS: The frequency of autoimmune diseases (21% vs 2%) and the frequency of autoantibodies (25% vs 2%) were both significantly (p<0.01) higher in DM2 patients compared with DM1 patients. Data on DM1 patients were comparable with the general population. Results were not confounded by smoking, medication use, familial clustering, age or sex. CONCLUSION: The results provide new insight into the clinical picture of DM2. In addition, possible explanations for the association between DM2 and autoimmune diseases are proposed.
BACKGROUND:Myotonic dystrophy type 2 (DM2) is a dominantly inherited multisystem disorder, characterised by progressive proximal weakness, myotonia, cataracts and cardiac conduction abnormalities. Our clinical impression of an association between DM2 and autoimmune diseases or autoantibody formation has not been published previously. OBJECTIVE: The aim of the present study was to investigate the frequency of autoimmune diseases and serum autoantibodies in patients with DM2 compared with patients with adult onset myotonic dystrophy type 1 (DM1). METHODS: 28 genetically proven Dutch DM2patients participated in the study and were compared with 51 age and sex matched adult onset DM1patients. As the primary outcome measure, the presence of an autoantibody or autoreactive T cell associated autoimmune disorder was assessed. As a secondary outcome measure, the presence of autoantibodies in serum (nuclear and non-nuclear antibodies) was assessed in all patients. RESULTS: The frequency of autoimmune diseases (21% vs 2%) and the frequency of autoantibodies (25% vs 2%) were both significantly (p<0.01) higher in DM2patients compared with DM1patients. Data on DM1patients were comparable with the general population. Results were not confounded by smoking, medication use, familial clustering, age or sex. CONCLUSION: The results provide new insight into the clinical picture of DM2. In addition, possible explanations for the association between DM2 and autoimmune diseases are proposed.
Authors: Eunhye Lee; Taeyun A Lee; Ji Hyun Kim; Areum Park; Eun A Ra; Sujin Kang; Hyun Jin Choi; Junhee L Choi; Hyunbin D Huh; Ji Eun Lee; Sungwook Lee; Boyoun Park Journal: Nucleic Acids Res Date: 2017-04-07 Impact factor: 16.971
Authors: Yongzhi Chen; Shruti Sharma; Patricia A Assis; Zhaozhao Jiang; Roland Elling; Andrew J Olive; Saiyu Hang; Jennifer Bernier; Jun R Huh; Christopher M Sassetti; David M Knipe; Ricardo T Gazzinelli; Katherine A Fitzgerald Journal: J Exp Med Date: 2018-11-15 Impact factor: 14.307
Authors: Łukasz J Sznajder; Marina M Scotti; Jihae Shin; Katarzyna Taylor; Franjo Ivankovic; Curtis A Nutter; Faaiq N Aslam; S H Subramony; Laura P W Ranum; Maurice S Swanson Journal: Nat Commun Date: 2020-04-24 Impact factor: 14.919